EE264 Cost-Effectiveness of Nivolumab Plus Platinum Doublet Chemotherapy as Neoadjuvant Treatment for Resectable NSCLC in Greece
Abstract
Authors
Mack S. Harris Fotios Diamantogiannis Pratishtha Khanduri Ariel Sun Benjamin White Sandra Milev Stefano Lucherini